These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30706527)

  • 1. Challenges in the management of people with diabetes and cancer.
    Chowdhury TA; Jacob P
    Diabet Med; 2019 Jul; 36(7):795-802. PubMed ID: 30706527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of diabetes in patients with cancer.
    Jacob P; Chowdhury TA
    QJM; 2015 Jun; 108(6):443-8. PubMed ID: 25362096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.
    Rowbottom L; Stinson J; McDonald R; Emmenegger U; Cheng S; Lowe J; Giotis A; Cheon P; Chow R; Pasetka M; Thavarajah N; Pulenzas N; Chow E; DeAngelis C
    Ann Palliat Med; 2015 Apr; 4(2):70-7. PubMed ID: 25971294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes: an Overview for Clinical Oncologists.
    Lee YN; Chowdhury TA
    Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):579-590. PubMed ID: 32299722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes.
    Gallo M; Muscogiuri G; Felicetti F; Faggiano A; Trimarchi F; Arvat E; Vigneri R; Colao A
    Metabolism; 2018 Jan; 78():141-154. PubMed ID: 28993227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.
    Roberts A; James J; Dhatariya K;
    Diabet Med; 2018 Aug; 35(8):1011-1017. PubMed ID: 30152586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
    Shah RR
    Drug Saf; 2017 Mar; 40(3):211-228. PubMed ID: 27981444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing hyperglycemia and diabetes in patients receiving enteral feedings: A health system approach.
    Mabrey ME; Barton AB; Corsino L; Freeman SB; Davis ED; Bell EL; Setji TL
    Hosp Pract (1995); 2015; 43(2):74-8. PubMed ID: 25744356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.
    Hussain S; Chowdhury TA
    Drugs; 2019 Feb; 79(3):231-242. PubMed ID: 30742277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Managing Patients with Type 1 Diabetes and Cancer.
    Best CJ; Thosani S; Ortiz M; Levesque C; Varghese SS; Lavis VR
    Curr Diab Rep; 2016 Aug; 16(8):73. PubMed ID: 27319323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic management during the inpatient enteral feeding of people with stroke and diabetes.
    Roberts AW; Penfold S;
    Diabet Med; 2018 Aug; 35(8):1027-1036. PubMed ID: 30152589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of steroid-induced hyperglycemia in hospitalized patients with cancer: a review.
    Brady VJ; Grimes D; Armstrong T; LoBiondo-Wood G
    Oncol Nurs Forum; 2014 Nov; 41(6):E355-65. PubMed ID: 25355031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient.
    Davidson P; Kwiatkowski CA; Wien M
    Nutr Clin Pract; 2015 Oct; 30(5):652-9. PubMed ID: 26084507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies.
    Schernthaner G; Schernthaner-Reiter MH
    Diabetologia; 2018 Jul; 61(7):1503-1516. PubMed ID: 29417185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of comorbid diabetes and cancer in the elderly].
    Ohashi K
    Nihon Rinsho; 2013 Nov; 71(11):2038-42. PubMed ID: 24397180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations.
    Elena C; Chiara M; Angelica B; Chiara MA; Laura N; Chiara C; Claudio C; Antonella F; Nicola G
    Curr Pharm Biotechnol; 2018; 19(15):1210-1220. PubMed ID: 30605054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review.
    Tatalovic M; Lehmann R; Cheetham M; Nowak A; Battegay E; Rampini SK
    BMJ Open; 2019 Jun; 9(5):e028914. PubMed ID: 31154314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemic-inducing neoadjuvant agents used in treatment of solid tumors: a review of the literature.
    Hershey DS; Bryant AL; Olausson J; Davis ED; Brady VJ; Hammer M
    Oncol Nurs Forum; 2014 Nov; 41(6):E343-54. PubMed ID: 25355030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of diabetes in terminal illness related to cancer.
    King EJ; Haboubi H; Evans D; Baker I; Bain SC; Stephens JW
    QJM; 2012 Jan; 105(1):3-9. PubMed ID: 21920998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.